What's new in DyslipidemiaLast update of the site: Tuesday September 19, 2023

Wijemunige Nilmini et al. | BMC Public Health 2023; 23(1): 1792
Identification of people at high risk for cardiovascular disease (CVD) and managing them with a combination...
Yin Dongpei et al. | Journal of Neuroinflammation 2023; 20(1):...
Despite considerable progress in acute recanalization therapies (i.e., intravenous thrombolysis and/or...
Garcia Agustin R. et al. | Respiratory Research 2023; 24(1): 223...
Pulmonary arterial hypertension (PAH) is a progressive disease leading to increased pulmonary vascular...
Garcia, Rosana Lima et al. | Blood Pressure Monitoring 2023; 28(5):...
Arterial hypertension (AH) is the main modifiable risk factor for cardiovascular disease and all-cause...
Rios Santiago et al. | Cardiovascular Diabetology 2023; 22(1):...
The role of lifestyle factors in health has been the object of numerous studies in recent decades. Most...
Huanxian Liu MD et al. | Headache 2023; 63(8): 1109-18
Migraine is a highly prevalent neurovascular disorder affecting more than 1 billion people worldwide....
Morace Carmela et al. | Italian Journal of Pediatrics 2023;...
Endocan, formerly called endothelial cell-specific molecule-1 (ESM-1), is a soluble dermatan sulfate...
Vistisen Dorte et al. | Cardiovascular Diabetology 2023; 22(1):...
Individuals with type 2 diabetes (T2D) are at increased risk for cardiovascular disease (CVD), including...
Shao Yubo et al. | Arthritis Research & Therapy 2023; 25(1):...
Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune disease of unknown etiology with erosive,...
Yi Jiayi et al. | Journal of Translational Medicine 2023;...
Despite decades of declining incidence rates and significant improvements in management and outcomes,...

Bibliographical searchFocus and target to your research of scientific data

Research by journal
957 articles currently available
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesThe 5 most read articles

Huanxian Liu MD et al. | Headache 2023; 63(8): 1109-18
Migraine is a highly prevalent neurovascular disorder affecting more than 1 billion people worldwide. It carries massive personal, social, and economic burdens, and is ranked as the second leading cause...
Yi Jiayi et al. | Journal of Translational Medicine 2023;...
Despite decades of declining incidence rates and significant improvements in management and outcomes, atherosclerotic cardiovascular disease (ASCVD) remains the major culprit for global morbidity and mortality...
Garcia Agustin R. et al. | Respiratory Research 2023; 24(1): 223...
Pulmonary arterial hypertension (PAH) is a progressive disease leading to increased pulmonary vascular resistance, right ventricular (RV) failure and eventually death. Despite survival has improved with...
Wijemunige Nilmini et al. | BMC Public Health 2023; 23(1): 1792
Identification of people at high risk for cardiovascular disease (CVD) and managing them with a combination of lifestyle advice and pharmacological treatment is a cornerstone of the World Health Organization...
Vistisen Dorte et al. | Cardiovascular Diabetology 2023; 22(1):...
Individuals with type 2 diabetes (T2D) are at increased risk for cardiovascular disease (CVD), including angina, myocardial infarction (MI), heart failure (HF), and stroke, which increases their health...